Written by The Care Clinic Team. Published by Resova Infusions and TMS. Medically reviewed by Dr. Siddharth Arora, DO, MS.
When Ketamine Infusion Might Change the Trajectory of Depression
Ketamine infusion has opened a real door for people whose depression has not shifted with standard medications. After years of treating complex mood disorders, we have seen ketamine help many patients experience relief when other treatments failed. For some, the change can come within days instead of weeks, which can matter a lot when life is already demanding and you are expected to keep up. That can feel especially sharp in the summer, when people around you may look relaxed and happy while you are still struggling to get out of bed. Ketamine works very differently from traditional antidepressants. Instead of primarily affecting serotonin or norepinephrine, ketamine acts on the glutamate system and can rapidly enhance neuroplasticity, your brain’s ability to form new connections. That mechanism helps explain why, for some individuals, the change can feel profound, especially in treatment-resistant depression. But the response is not uniform, and benefits can fade over time without a thoughtful maintenance plan. In our work with complex mood disorders, we see a wide range of outcomes. Many patients have meaningful relief, some feel a profound shift, and others notice little change even with a careful course of ketamine. The big question we ask with each person is: based on who you are, your body, your brain, and how you respond to early sessions, how likely is ketamine infusion to actually help your depression?What Predicting Ketamine Response Really Means
When we talk about predicting response, we are talking about probabilities, not certainties. Two people with long histories of treatment-resistant depression can sit in the same chair, receive the same dose, and walk away with very different results. It helps to be clear about a few terms we use every day in our Fairfax psychiatry and infusion practice:- Treatment-resistant depression: usually means you have tried several antidepressants at solid doses and for long enough, without good relief
- Response: noticeable improvement in symptoms, but not full relief
- Remission: symptoms are minimal or gone, and daily life feels workable again
- Acute response: what happens in the hours to weeks after ketamine infusions
- Sustained benefit: how much of that improvement holds up over months
Biomarkers Under Study: Brain, Blood, and Beyond
Researchers are working hard to find better ways to predict who will respond to ketamine. Some of the most discussed ideas are “biomarkers,” clues in the brain or body that might give us a hint. Areas under study include:- Brain activity patterns on EEG
- Functional MRI findings that show how brain regions talk to each other
- Inflammatory markers in the blood, like C-reactive protein (CRP)
- Levels of brain-derived neurotrophic factor (BDNF), which is linked to neuroplasticity
- Measures related to glutamate, the main signaling system ketamine affects
Clinical Clues and Early-Session Changes
In day-to-day psychiatry, clinical patterns often tell us more than lab tests. People who may be more likely to benefit from ketamine infusion often share features like:- Clear history of major depressive episodes
- Multiple failed antidepressant or augmentation trials
- Deep anhedonia, where almost nothing feels rewarding
- Significant loss of function at work, school, or home over time
- Coexisting anxiety, PTSD, or bipolar spectrum features
- Longstanding personality traits that affect relationships or coping
- Substance use history, including alcohol or stimulants
- Chronic pain conditions and other medical problems
- Shifts in overall mood “load,” even if small
- Reduction in suicidal thoughts or intensity of hopelessness
- Changes in energy, motivation, or ability to start tasks
- Sleep quality and patterns
- A sense of being “less stuck” or more flexible in thinking
Integrating Ketamine, TMS, and Ongoing Care Over Time
We see ketamine infusion and TMS as tools in a larger plan, not last resorts. For long-standing, seasonal, or recurrent depression, it is rare that a single treatment solves everything forever. Ketamine’s benefits are often time-limited. Some patients experience a clear lift that gradually fades over weeks to months. Because of that, we plan from the beginning for how to sustain gains, which may include:- Booster ketamine infusions spaced out over time, when clinically appropriate
- Ongoing psychotherapy to make use of new flexibility in thinking
- Medication adjustments once mood has lifted enough to tolerate change
- A later TMS course to build more stable improvement
- Mood and anxiety ratings
- Side effect tracking
- Questions about work, relationships, and daily self-care
- Regular review of diagnosis as your brain and symptoms shift with treatment
How Careful Screening and Oversight Protect Your Progress
Good outcomes start with careful screening. At Resova Infusions and TMS, our evaluation usually includes:- A detailed psychiatric interview and review of past treatment trials
- Medical history and current medications
- Lab work when appropriate, based on your health and safety needs
- Substance use and safety assessment, including risk of self-harm
- Cardiovascular and respiratory monitoring
- Review of potential medication interactions
- Clear guidance about driving and important decisions on treatment days
- Protocols to respond to blood pressure changes, nausea, anxiety, or non-response
Take The First Step Toward Lasting Relief Today
If you are ready to explore a different approach to managing your symptoms, we are here to walk you through each step. At Resova Infusions and TMS, our experienced team will help you determine whether a tailored ketamine infusion plan is right for you. Reach out to schedule a consultation so we can review your history, answer your questions, and outline your next best steps. Let us partner with you to move toward relief, stability, and a better quality of life.Clinical context and sources
TMS devices have FDA clearance for specific indications. Eligibility, risks and likely benefits depend on the device, protocol and condition being treated. NIMH: Brain Stimulation Therapies.
IV ketamine for depression is an off-label treatment. It is distinct from FDA-approved intranasal esketamine; a clinician must assess suitability and monitoring needs. NIMH: Cracking the Ketamine Code (2023).
These references provide context for the topics discussed. They do not establish that a particular treatment is appropriate for every reader or guarantee an individual outcome.